Diluting postmortem bile can improve drug analysis by reducing interference from the specimen itself. In a 108-target LC–MS/MS study, 1:100 dilution performed better than undiluted bile or 1:10 dilution. Yet the authors still identified problematic suppression for buprenorphine and THC-COOH. The headline target count therefore did not mean every compound had equally satisfactory performance.
Why dilution was part of the method
Franzin and colleagues developed a bile method covering drugs and metabolites across several classes. They compared pure bile with bile diluted in phosphate-buffered saline at 1:10 and 1:100. Pure bile created analytical difficulties, while 1:100 reduced matrix effects relative to 1:10 and retained sufficient sensitivity for low-concentration analytes.
Dilution trades reduced matrix burden against reduced analyte signal. Its success depends on the complete procedure and the compound being measured. The study does not establish 1:100 as the preferred dilution for every bile assay, instrument or target.
Calibrators and controls came from a commercial lyophilized mixture reconstituted in the matrix under evaluation. The procedure used 50 µL of sample, internal standards and beta-glucuronidase, with two hours of incubation at 45°C before protein precipitation. It did not require solid-phase extraction.
The result depended on preparation and calibration
Enzymatic deconjugation changes what can contribute to the measured analyte signal. A result from this hydrolyzed preparation should not be treated automatically as the free-analyte concentration from an untreated specimen. The dilution and calibration basis also need to remain attached to any numerical report.
The main paper displayed detailed performance for 12 representative compounds, with additional analyte-level information assigned to supplementary material. Its main-table findings should not be expanded into independently checked performance claims for all 108 targets.
For the displayed validation, calibration correlations exceeded R² = 0.99. Accuracy and precision used three control levels tested three times within a day and in three different runs. Reported precision was no greater than 15%, with accuracy within 100 ± 15% of target. Six blank bile specimens were used to investigate selectivity.
Table 2 reported morphine detection and quantitation limits of 0.21 and 1.08 µg/L, respectively, and methadone limits of 4.55 and 28.50 µg/L. These are different analytical endpoints and belong to this stated preparation and calibration. They are not blood concentrations or toxicity thresholds, and they should not be multiplied again by a dilution factor without establishing the reporting basis.
Two compounds remained important exceptions
The authors identified matrix suppression for buprenorphine and 11-nor-9-carboxy-THC, usually called THC-COOH, and concluded that the method was not ideal for these targets. A general statement about satisfactory bile performance therefore needs this qualification.
Internal standards and a sensitive mass spectrometer do not eliminate the need for target-specific validation. Suppression concerns analytical response; it is not proof of drug degradation in the body. Nor does poor performance for two targets invalidate every other measurement in the panel.
What the 13-case application demonstrated
The method was applied to specimens from 13 forensic individuals with suspected intoxication or overdose. Blood came from the femoral vein; urine and bile were also collected at autopsy. Leftover specimens were stored at −20°C. The report did not establish a uniform death-to-collection interval.
All prepared case samples had been positive on initial immunoassay screening. This selected application therefore cannot establish sensitivity among all screen-negative deaths or population drug prevalence. The paper also gives inconsistent drug-frequency percentages across its abstract and results; those percentages should not be treated as a reconciled prevalence estimate.
Its reported frozen stability concerned diluted-bile quality controls tested after one week and one month at −20°C, with supporting results described as unchanged but not displayed. This does not demonstrate stability in a decomposing body, at room temperature, or through repeated freezing and thawing.
What a bile concentration can support
This work supports a specified quantitative preparation with explicit target limitations. It does not validate conversion of bile into an antemortem blood concentration or determine impairment or cause of death from a positive result.
A later, separate study evaluated qualitative bile immunoassay agreement with confirmation. That screening question differs from whether this diluted LC–MS/MS procedure accurately quantifies a particular compound. Keep both questions separate when reviewing a case.
Primary source
Franzin M, Ruoso R, Peruch M, Stocco G, D’Errico S, Addobbati R. Quantification of 108 illicit drugs and metabolites in bile matrix by LC–MS/MS for the toxicological testing of sudden death cases. Archives of Toxicology. 2024;98:135–149. doi:10.1007/s00204-023-03631-z.
Leave a Reply